MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

PRevention of Acute Kidney Injury Initiated With Electronic Surveillance Enhancement

Not Applicable

Completed

Conditions: Acute Kidney Injury

Interventions: Other: Conventional management arm
Other: AKI sniffer instigated AKI management

First Posted Date: 2012-06-18

Last Posted Date: 2022-06-22

Lead Sponsor: Mayo Clinic

Target Recruit Count: 2266

Registration Number: NCT01621152

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

"Dusting" Versus "Basketing" - Treatment Of Intrarenal Stones

Completed

Conditions: Nephrolithiasis
Kidney Calculi
Renal Stones
Kidney Stones

First Posted Date: 2012-06-14

Last Posted Date: 2018-09-18

Lead Sponsor: Mayo Clinic

Target Recruit Count: 178

Registration Number: NCT01619735

Locations: 🇺🇸
James Buchanan Brady Urological Institute, Baltimore, Maryland, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Ohio State University, Columbus, Ohio, United States

and more 6 locations

EUS Guided Celiac Neurolysis

Not Applicable

Completed

Conditions: Pancreatic Cancer Pain

Interventions: Procedure: EUS

First Posted Date: 2012-06-08

Last Posted Date: 2017-07-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 110

Registration Number: NCT01615653

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

A Randomized Study of Approaches in Total Hip Arthroplasty

Not Applicable

Completed

Conditions: Total Hip Replacement

Interventions: Procedure: Direct Anterior Approach
Procedure: Mini-Posterior Approach

First Posted Date: 2012-06-07

Last Posted Date: 2018-12-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 116

Registration Number: NCT01613508

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Early or Late Foley Removal After Thoracotomy

Completed

Conditions: Urinary Tract Infections

First Posted Date: 2012-06-05

Last Posted Date: 2016-09-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 375

Registration Number: NCT01611519

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Venlafaxine in Preventing Chronic Oxaliplatin-Induced Neuropathy In Patients Receiving Combination Chemotherapy

Not Applicable

Completed

Conditions: Peripheral Neuropathy

Interventions: Drug: placebo
Drug: venlafaxine
Other: questionnaire administration
Other: quality-of-life assessment

First Posted Date: 2012-06-04

Last Posted Date: 2019-09-26

Lead Sponsor: Mayo Clinic

Target Recruit Count: 50

Registration Number: NCT01611155

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Code Status Video in the Intensive Care Unit: Video Assisted Patient Education

Phase 1

Completed

Conditions: Critical Illness

Interventions: Other: Code Status Video

First Posted Date: 2012-06-01

Last Posted Date: 2016-05-13

Lead Sponsor: Mayo Clinic

Target Recruit Count: 208

Registration Number: NCT01610076

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Evaluation of an Antidepressant Pharmacogenomic Algorithm in an Outpatient Clinical Setting

Not Applicable

Completed

Conditions: Depression

Interventions: Other: Pharmacogenomic algorithm

First Posted Date: 2012-06-01

Last Posted Date: 2017-03-30

Lead Sponsor: Mayo Clinic

Target Recruit Count: 227

Registration Number: NCT01610063

Locations: 🇺🇸
Franciscan Skemp HealthCare, La Crosse, Wisconsin, United States

A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

Phase 1

Completed

Conditions: Amyotrophic Lateral Sclerosis

Interventions: Biological: autologous mesenchymal stem cells

First Posted Date: 2012-05-31

Last Posted Date: 2019-09-03

Lead Sponsor: Mayo Clinic

Target Recruit Count: 27

Registration Number: NCT01609283

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States

Normative Values for Cognitive Testing and Alzheimer's Imaging Biomarkers in Young Adults

Phase 1

Completed

Conditions: Alzheimer's Disease

Interventions: Drug: F-18 FDG
Drug: C-11 PiB

First Posted Date: 2012-05-31

Last Posted Date: 2014-08-08

Lead Sponsor: Mayo Clinic

Target Recruit Count: 41

Registration Number: NCT01609335

Locations: 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy